Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Julie Park
New Approaches to Neuroblastoma Treatment (NANT)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital for Sick Children
Toronto, Ontario, Canada
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S Healthcare of Atlanta - Egleston
Atlanta, Georgia, United States
- University of Chicago Comer Children'S Hospital
Chicago, Illinois, United States
- Boston Children'S Hospital
Boston, Massachusetts, United States
- C S Mott Children'S Hospital
Ann Arbor, Michigan, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Cook Children'S Medical Center
Fort Worth, Texas, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2010
- Primary completion
- 30 Sept 2014
- Completion
- —
- Last update posted
- 24 Nov 2015
- Registered enrollment
- 29
- Registry id
- NCT01208454
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.